@article{8dcfe0ca5150467f8cc6f575c1d99178,
title = "Fine-mapping classical HLA variation associated with durable host control of HIV-1 infection in african americans",
author = "{The International HIV Controllers Study} and McLaren, {Paul J.} and Stephan Ripke and Kimberly Pelak and Weintrob, {Amy C.} and Patsopoulos, {Nikolaos A.} and Xiaoming Jia and Erlich, {Rachel L.} and Lennon, {Niall J.} and Kadie, {Carl M.} and David Heckerman and Namrata Gupta and Haas, {David W.} and Deeks, {Steven G.} and Florencia Pereyra and Walker, {Bruce D.} and {de Bakker}, {Paul I.W.} and Kuritzkes, {Daniel R.} and Robbins, {Gregory K.} and Shafer, {Robert W.} and Gulick, {Roy M.} and Shikuma, {Cecilia M.} and Richard Haubrich and Sharon Riddler and Sax, {Paul E.} and Daar, {Eric S.} and Ribaudo, {Heather J.} and Addo, {Marylyn M.} and Brian Agan and Shanu Agarwal and Ahern, {Richard L.} and Allen, {Brady L.} and Sherly Altidor and Altschuler, {Eric L.} and Sujata Ambardar and Kathryn Anastos and Val Anderson and Ushan Andrady and Diana Antoniskis and David Bangsberg and Daniel Barbaro and William Barrie and J. Bartczak and Simon Barton and Patricia Basden and Nesli Basgoz and Bellos, {Nicholaos C.} and Judith Berger and Bernard, {Nicole F.} and Bernard, {Annette M.} and Duncan Webster",
note = "Funding Information: Additional support for this work was provided by the Infectious Disease Clinical Research Program (IDCRP), a Department of Defense (DoD) program executed through the Uniformed Services University of the Health Sciences. This project has been funded in whole, or in part, with federal funds from the National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), under Inter-Agency Agreement Y1-AI-5072. Funding Information: This work was made possible through a generous donation from the Mark and Lisa Schwartz Foundation and a subsequent award from the Collaboration for AIDS Vaccine Discovery (CAVD) of the Bill and Melinda Gates Foundation. This work was also supported in part by the Harvard University Center for AIDS Research (P-30-AI060354), UCSF CFAR (P-30 AI27763), UCSF CTSI (UL1 RR024131), CNICS (R24 AI067039), Vanderbilt CTSA (RR024975), NIH grants AI28568, AI030914 (B.D.W.); AI087145, K24AI069994 (S.G.D.); AI069513, AI34835, AI069432, AI069423, AI069477, AI069501, AI069474, AI069428, AI69467, AI069415, Al32782, AI27661, AI25859, AI28568, AI30914, AI069495, AI069471, AI069532, AI069452, AI069450, AI069556, AI069484, AI069472, AI34853, AI069465, AI069511, AI38844, AI069424, AI069434, AI46370, AI68634, AI069502, AI069419, AI068636, RR024975 (AIDS Clinical Trials Group); AI077505 and MH071205 (D.W.H.). S.R. acknowledges support from NIH/ NIMH (MH085520).",
year = "2012",
month = jan,
day = "1",
doi = "10.1093/hmg/dds226",
language = "English",
volume = "21",
pages = "4334--4347",
journal = "Human Molecular Genetics",
issn = "0964-6906",
publisher = "Oxford University Press",
number = "19",
}
